Solid tumors, prevalent across various systems such as the respiratory, digestive, urinary, and gynecologic systems, constitute a significant challenge in adult oncology. These tumors are ...

Sartorius has launched a new genetically engineered CHO host cell line designed to improve productivity and efficiency.

New research describes multimodal sensor fusion for AI-based fault detection in 3D printing.

This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.

Abstract: Detecting small objects in remote sensing images poses significant challenges to the field of computer vision, primarily stemming from the complexity of backgrounds, limitations in pixel ...

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune ...

U.S. scientists have discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, ...

The research in this week’s report investigates new energy storage materials and processes and advanced nuclear and fusion power ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Nuclear fusion group SHINE Technologies said it has raised $240 million in equity funding to advance the company's commercial ...

Positive Phase 3 data from ORIGIN 3 study of atacicept in IgA nephropathy (IgAN) presented at American Society of Nephrology (ASN) Kidney Week ...

SHINE Technologies, a nuclear fusion company, today announced it has raised $240 million in equity funding, and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder ...